Kyle Rose

Stock Analyst at Canaccord Genuity

(3.38)
# 875
Out of 4,853 analysts
114
Total ratings
53.26%
Success rate
13.82%
Average return

Stocks Rated by Kyle Rose

Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $30.30
Upside: -10.89%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304$324
Current: $317.16
Upside: +2.16%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420$435
Current: $383.10
Upside: +13.55%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67$71
Current: $59.55
Upside: +19.23%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65$71
Current: $31.60
Upside: +124.68%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55$22
Current: $14.34
Upside: +53.42%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.60
Upside: +525.00%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17$22
Current: $12.44
Upside: +76.85%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135$150
Current: $85.74
Upside: +74.95%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360$270
Current: $7.65
Upside: +3,429.41%
Maintains: Buy
Price Target: $24$27
Current: $19.06
Upside: +41.66%
Reiterates: Buy
Price Target: $15
Current: $1.95
Upside: +669.23%
Reiterates: Buy
Price Target: $15
Current: $10.80
Upside: +38.89%
Maintains: Market Perform
Price Target: $125$122
Current: $178.56
Upside: -31.68%
Upgrades: Buy
Price Target: $3$4
Current: $2.91
Upside: +37.46%
Downgrades: Hold
Price Target: n/a
Current: $6.49
Upside: -
Downgrades: Hold
Price Target: $165$125
Current: $91.92
Upside: +35.99%